[D66] Fauci introduceert Post-Acute SARS-CoV-2-infectie (PASC)

[Dr. Marc-Alexander Fluks]

[...hier kijken politici uiteraard nog steeds voor weg...]

Bron:   Medisch Contact
Datum:  26 februari 2021
Auteur: Eva Nyst
URL:    
https://www.medischcontact.nl/nieuws/laatste-nieuws/nieuwsartikel/fauci-introduceert-pasc-als-naam-voor-klachten-na-covid-.htm


Fauci introduceert PASC als naam voor klachten na covid
-------------------------------------------------------

De Amerikaanse topimmunoloog Anthony Fauci heeft tijdens een 
persconferentie afgelopen woensdag het acroniem PASC geintroduceerd voor 
de klachten die kunnen optreden na het doorlopen van een 
SARS-CoV-2-infectie. Dat meldt de Amerikaanse website Medscape.

Vermoeidheid, kortademigheid, slaapstoornissen, koorts, 
gastro-intestinale symptomen, angst en depressie en wat sommigen brain 
fog noemen, niet of moeizaam kunnen concentreren of focussen', somde 
Fauci de symptomen tijdens de persconferentie op. We noemen dit long 
covid, zei hij. 'Maar wat dat eigenlijk is, zijn post-acute gevolgen van 
SARS-CoV-2-infectie, waarnaar we nu verwijzen als PASC.'

Fauci is directeur van het Amerikaanse Nationaal Instituut voor Allergie 
en Infectieziekten (NIAID), onderdeel van de National Institutes of 
Health (NIH). Tijdens de persconferentie maakte hij bekend dat het 
Amerikaanse congres de komende vier jaar 1,15 miljard dollar vrijmaakt 
voor onderzoek naar PASC door het NIH.

In een beleidsnota adviseerde de WHO gisteren gecoordineerde, 
multidisciplinaire, nationale en internationale studies te doen om de 
klinische impact van postcovidaandoeningen te begrijpen. De onderzoeken 
zouden samen met patienten en zorgverleners moeten worden opgezet.

--------
(c) 2021 Medisch Contact

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Bron:   Medscape
Datum:  24 februari 2021
Auteur: Lindsay Kalter
URL:    https://www.medscape.com/viewarticle/946419


Fauci Introduces New Acronym for Long COVID at White House Briefing
-------------------------------------------------------------------

As officials scramble to get vaccines and protective gear to the public, 
scientists are working overtime to gain knowledge of the long-term 
effects of COVID-19, said Anthony Fauci, MD, during a wide-ranging 
briefing at the White House today. 'Many of you are now aware of what 
had long been called 'long COVID,' ' said Fauci, the White House 
COVID-19 Response Team's chief medical adviser. 'But actually, what that 
really is is post-acute sequelae of SARS-CoV-2 infection, which we're 
now referring to as 'PASC,' or P-A-S-C.'

He noted that the National Institutes of Health launched an initiative 
yesterday to further study the phenomenon, which Fauci called 'alarming' 
and 'puzzling.'

He stressed that even patients with moderate cases of the infection can 
develop PASC. Symptoms include fatigue; gastrointestinal problems; 
'brain fog,' or an inability to focus; depression; anxiety; sleep 
difficulties; and, in extreme cases, impaired lung capacity. 'New 
symptoms sometimes arise well after the time of infection, or they 
evolve over time and persist for months,' Fauci continued. 'They can 
range from mild or annoying to actually quite incapacitating.' He 
referred to a study from researchers at the University of Washington 
that was published online February 19 in JAMA Network Open. In that 
study, more than 30% of the 177 participants reported symptoms that 
persisted for up to 9 months. It's very difficult to treat something 
when you don't know what the target of that treatment is,' Fauci said. 
'There are a lot of important questions with this series of initiatives 
that we will ultimately answer.'


White House Will 'Waste No Time' Distributing J&J Vaccine

US Food and Drug Administration scientists determined that the Johnson & 
Johnson vaccine is safe and effective, according to a review released 
today. Once the single-dose vaccine receives emergency use authorization 
― which is expected later this week ― the administration will begin 
working immediately to distribute it. 'Governors are carefully planning 
their efforts and getting ready for the possible new vaccine,' said 
White House COVID-19 Coordinator Jeff Zients in a press briefing this 
morning. 'If authorized, we are ready to roll out this vaccine without 
delay.'

The Johnson & Johnson vaccine, which would be the third for the pandemic 
that has killed more than 500,000 Americans, was found to be more than 
85% effective in preventing severe illness and 66% protective overall.

Zients said that if emergency use authorization is granted, three to 
four million doses will be delivered by next week and that 20 million 
are slated to be delivered by the end of March. Johnson & Johnson is 
required by contract to deliver 100 million doses by the end of June. 
'While we await the decision, we want the American people to know we're 
doing the work so if the emergency use authorization is granted, we'll 
waste no time getting the lifesaving vaccine into the arms of 
Americans,' Zients said.

When the Biden administration assumed power 5 weeks ago, Zients said, it 
became clear the company was behind on manufacturing. Since then, the 
White House has helped with equipment and raw materials to accelerate 
the process. 'It was disappointing when we arrived,' Zients said, 'and I 
think the progress is real.'

The White House response team also announced during the briefing that 
they will deliver 25 million fitted cloth masks for adults and children 
to health centers and food banks nationwide in a continued effort to 
protect underserved Americans.

--------
(c) 2021 WebMD LLC.